<?xml version="1.0" encoding="UTF-8"?>
<ref id="B136">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Osorio</surname>
    <given-names>J. E.</given-names>
   </name>
   <name>
    <surname>Velez</surname>
    <given-names>I. D.</given-names>
   </name>
   <name>
    <surname>Thomson</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Lopez</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Jimenez</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Haller</surname>
    <given-names>A. A.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2014</year>). 
  <article-title>Safety and immunogenicity of a recombinant live attenuated tetravalent dengue vaccine (DENVax) in flavivirus-naive healthy adults in Colombia: a randomised, placebo-controlled, phase 1 study.</article-title>
  <source>
   <italic>Lancet Infect Dis.</italic>
  </source>
  <volume>14</volume>
  <fpage>830</fpage>â€“
  <lpage>838</lpage>. 
  <pub-id pub-id-type="doi">10.1016/S1473-3099(14)70811-4</pub-id>
  <?supplied-pmid 25087476?>
  <pub-id pub-id-type="pmid">25087476</pub-id>
 </mixed-citation>
</ref>
